As supernatants of TRAIL-treated cells were also able to polarize human CD14+ cells toward HLA-DRlo/neg CD206+ cells in vitro, it is conceivable that TRAIL-induced cytokines may not only recruit myeloid cells to, but also promote their polarization within, the tumor microenvironment. This evidence concerns the gene MRC1 and neoplasm.